|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
355,150,000 |
Market
Cap: |
2.44(B) |
Last
Volume: |
17,273,575 |
Avg
Vol: |
17,225,814 |
52
Week Range: |
$5.72 - $10.61 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a range of: pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices). Co.'s portfolio of products falls into four operating and reportable segments: Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
6,313 |
6,533 |
13,261 |
14,828 |
Total Sell Value |
$61,867 |
$63,491 |
$119,170 |
$133,715 |
Total People Sold |
1 |
1 |
1 |
1 |
Total Sell Transactions |
1 |
2 |
4 |
7 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Carson Seana |
EVP, General Counsel |
|
2023-09-05 |
4 |
D |
$8.35 |
$428,664 |
D/D |
(51,337) |
391,898 |
|
- |
|
Barresi John S |
SVP, Controller & CAO |
|
2023-09-05 |
4 |
D |
$8.35 |
$33,250 |
D/D |
(3,982) |
71,126 |
|
- |
|
Appio Thomas |
Chief Executive Officer |
|
2023-09-01 |
4 |
D |
$8.46 |
$119,379 |
D/D |
(14,111) |
967,010 |
|
- |
|
Robertson Russel C |
Director |
|
2023-06-30 |
4 |
A |
$8.00 |
$31,248 |
D/D |
3,906 |
214,637 |
|
- |
|
Wechsler Amy B |
Director |
|
2023-06-30 |
4 |
A |
$8.00 |
$6,872 |
D/D |
859 |
167,566 |
|
- |
|
Paulson John |
Director |
|
2023-06-30 |
4 |
A |
$8.00 |
$62,496 |
D/D |
7,812 |
187,023 |
|
- |
|
Icahn Brett |
Director |
|
2023-06-30 |
4 |
A |
$8.00 |
$33,120 |
D/D |
4,140 |
97,219 |
|
- |
|
Barresi John S |
SVP, Controller & CAO |
|
2023-06-20 |
4 |
D |
$7.40 |
$14,275 |
D/D |
(1,929) |
75,108 |
|
- |
|
Robertson Russel C |
Director |
|
2023-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
29,205 |
210,731 |
|
- |
|
Wechsler Amy B |
Director |
|
2023-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
29,205 |
166,707 |
|
- |
|
Miller Steven D |
Director |
|
2023-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
29,205 |
139,517 |
|
- |
|
Power Robert N |
Director |
|
2023-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
29,205 |
165,016 |
|
- |
|
Ross Thomas W. Sr. |
Director |
|
2023-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
29,205 |
161,516 |
|
- |
|
Mulligan Richard |
Director |
|
2023-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
29,205 |
65,909 |
|
- |
|
Kavanagh Sarah B |
Director |
|
2023-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
29,205 |
146,652 |
|
- |
|
Paulson John |
Director |
|
2023-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
29,205 |
179,211 |
|
- |
|
Icahn Brett |
Director |
|
2023-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
29,205 |
93,079 |
|
- |
|
Carson Seana |
EVP, General Counsel |
|
2023-03-06 |
4/A |
AS |
$9.17 |
$4,539 |
D/D |
(495) |
443,235 |
|
- |
|
Carson Seana |
EVP, General Counsel |
|
2023-03-06 |
4 |
D |
$9.17 |
$4,539 |
D/D |
(495) |
443,235 |
|
- |
|
Carson Seana |
EVP, General Counsel |
|
2023-03-03 |
4/A |
AS |
$9.34 |
$7,285 |
D/D |
(780) |
443,730 |
|
- |
|
Appio Thomas |
Chief Executive Officer |
|
2023-03-03 |
4 |
D |
$9.16 |
$93,203 |
D/D |
(10,175) |
981,121 |
|
- |
|
Carson Seana |
EVP, General Counsel |
|
2023-03-03 |
4 |
D |
$9.16 |
$42,093 |
D/D |
(4,580) |
443,730 |
|
- |
|
Vadaketh Tom George |
EVP, Chief Financial Officer |
|
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
142,678 |
608,881 |
|
- |
|
Vadaketh Tom George |
EVP, Chief Financial Officer |
|
2023-03-02 |
4 |
D |
$9.25 |
$37,009 |
D/D |
(4,001) |
466,203 |
|
- |
|
Appio Thomas |
Chief Executive Officer |
|
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
523,155 |
991,296 |
|
- |
|
705 Records found
|
|
Page 2 of 29 |
|
|